These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32040880)

  • 1. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP).
    Mozdiak E; Wicaksono AN; Covington JA; Arasaradnam RP
    Tech Coloproctol; 2019 Apr; 23(4):343-351. PubMed ID: 30989415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening.
    Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A
    Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J; Cleary S; Gray L; Datt P; Goudie DR; Steele RJC; Strachan JA; Humphries A; Fraser CG; Mowat C
    United European Gastroenterol J; 2020 Jun; 8(5):559-566. PubMed ID: 32213041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps.
    He X; Hang D; Wu K; Nayor J; Drew DA; Giovannucci EL; Ogino S; Chan AT; Song M
    Gastroenterology; 2020 Mar; 158(4):852-861.e4. PubMed ID: 31302144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of Surveillance Colonoscopy to Colorectal Cancer Prevention.
    Pinsky PF; Schoen RE
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2937-2944.e1. PubMed ID: 32017987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
    McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
    Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low detection rate of advanced neoplasia within 5 years after polypectomy of small serrated adenoma.
    Jin D; Cao H; Shah BK; Chen D; Zhang Y; Liu T; Dong W; Wang S; Qi Y; Wang B
    Postgrad Med J; 2019 Apr; 95(1122):187-192. PubMed ID: 30926717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer and advanced adenoma incidence during post-polypectomy surveillance: a national cohort study in the English Bowel Cancer Screening Programme.
    Bonnington SN; Hungin APS; Nickerson C; Wright S; Sharp L; Rutter MD
    Endoscopy; 2023 Aug; 55(8):740-753. PubMed ID: 37185968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breath testing as potential colorectal cancer screening tool.
    Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
    Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer.
    Mouchli MA; Ouk L; Scheitel MR; Chaudhry AP; Felmlee-Devine D; Grill DE; Rashtak S; Wang P; Wang J; Chaudhry R; Smyrk TC; Oberg AL; Druliner BR; Boardman LA
    World J Gastroenterol; 2018 Feb; 24(8):905-916. PubMed ID: 29491684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.
    Pérez-Cuadrado-Robles E; Torrella-Cortés E; Bebia-Conesa P; Quesada-Vázquez N; Rodrigo-Agudo JL; Chacón-Martínez S; López-Martín A; Esteban-Delgado P; Pérez-Cuadrado-Martínez E; Pérez-Riquelme F
    Dig Endosc; 2016 May; 28(4):450-455. PubMed ID: 26538148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.